HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nature’s Youth Supplement Relabeled Without Growth Factor Reference

This article was originally published in The Tan Sheet

Executive Summary

Marketing of Nature's Youth dietary supplement has resumed in packaging that no longer refers to human growth factor or anti-aging claims, the product's Centerville, Mass.-based marketer said. The supplement's name also has been revised from Nature's Youth hGH

You may also be interested in...



“Human Growth Hormone” Supplement Ads Lead NEJM To Contact State AGs

The New England Journal of Medicine has contacted the Massachusetts and New Jersey Attorneys General about the advertising practices of some "human growth hormone" marketers, Editor-in-Chief Jeffrey Drazen, MD, says in a perspective paper titled "Inappropriate Advertising of Dietary Supplements" that appears in the Feb. 27 issue

FDA Warning Letters Increasingly Targeting Internet Claims

More than 80% of the warning letters concerning OTC drug and dietary supplement products sent in the last few months have focused on Internet claims

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS128904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel